Daiichi Sankyo (OTCMKTS:DSNKY) Hits New 1-Year Low – What’s Next?

Shares of Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Free Report) hit a new 52-week low on Wednesday . The stock traded as low as $22.76 and last traded at $22.99, with a volume of 213654 shares changing hands. The stock had previously closed at $23.78.

Daiichi Sankyo Stock Performance

The firm’s 50-day moving average price is $26.60 and its two-hundred day moving average price is $31.59. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.11 and a current ratio of 2.77. The stock has a market cap of $43.22 billion and a price-to-earnings ratio of 26.34.

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.22 earnings per share for the quarter. Daiichi Sankyo had a net margin of 13.62% and a return on equity of 14.53%. On average, analysts expect that Daiichi Sankyo Company, Limited will post 0.73 EPS for the current fiscal year.

About Daiichi Sankyo

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Recommended Stories

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.